199 related articles for article (PubMed ID: 23924646)
41. Androgen receptors in Dupuytren's contracture.
Pagnotta A; Specchia N; Greco F
J Orthop Res; 2002 Jan; 20(1):163-8. PubMed ID: 11853085
[TBL] [Abstract][Full Text] [Related]
42. The cytoskeleton and extracellular matrix of the Dupuytren's disease "myofibroblast": an immunofluorescence study of a nonmuscle cell type.
Tomasek JJ; Schultz RJ; Episalla CW; Newman SA
J Hand Surg Am; 1986 May; 11(3):365-71. PubMed ID: 3519746
[TBL] [Abstract][Full Text] [Related]
43. [The pathobiochemistry of Dupuytren's contracture].
Bobiński R
Chir Narzadow Ruchu Ortop Pol; 2009; 74(2):68-73. PubMed ID: 19514484
[TBL] [Abstract][Full Text] [Related]
44. Patients with Dupuytren's Contracture, Ledderhose Disease, and Peyronie's Disease are at higher risk of arthrofibrosis following total knee arthroplasty.
Wang CX; Flick TR; Patel AH; Sanchez F; Sherman WF
Knee; 2021 Mar; 29():190-200. PubMed ID: 33640618
[TBL] [Abstract][Full Text] [Related]
45. The biochemistry of Dupuytren's disease.
Badalamente MA; Hurst LC
Hand Clin; 1999 Feb; 15(1):35-42, v-vi. PubMed ID: 10050240
[TBL] [Abstract][Full Text] [Related]
46. Echogenicity of Dupuytren's nodules is correlated to myofibroblast load and nodule hardness.
Molenkamp S; Song W; Bloembergen M; Broekstra DC; Werker PMN
J Hand Surg Eur Vol; 2022 Mar; 47(3):280-287. PubMed ID: 34617826
[TBL] [Abstract][Full Text] [Related]
47. Regulation of expression of alpha-smooth muscle actin in cells of Dupuytren's contracture.
Hindman HB; Marty-Roix R; Tang JB; Jupiter JB; Simmons BP; Spector M
J Bone Joint Surg Br; 2003 Apr; 85(3):448-55. PubMed ID: 12729127
[TBL] [Abstract][Full Text] [Related]
48. [Dupuytren's disease. State of the art and therapeutic perspectives].
Corrado A; Cantatore FP
Reumatismo; 2007; 59(2):118-28. PubMed ID: 17603691
[TBL] [Abstract][Full Text] [Related]
49. Involvement of pro-inflammatory cytokines and growth factors in the pathogenesis of Dupuytren's contracture: a novel target for a possible future therapeutic strategy?
Bianchi E; Taurone S; Bardella L; Signore A; Pompili E; Sessa V; Chiappetta C; Fumagalli L; Di Gioia C; Pastore FS; Scarpa S; Artico M
Clin Sci (Lond); 2015 Oct; 129(8):711-20. PubMed ID: 26201022
[TBL] [Abstract][Full Text] [Related]
50. The Effect of Chitosan Derivatives on the Compaction and Tension Generation of the Fibroblast-populated Collagen Matrix.
Doan KT; Kshetri P; Attamakulsri N; Newsome DR; Zhou F; Murray CK; Chen WR; Xu G; Vaughan MB
Molecules; 2019 Jul; 24(15):. PubMed ID: 31357389
[TBL] [Abstract][Full Text] [Related]
51. Dupuytren's contracture: morphological and biochemical changes in palmar aponeurosis.
Hamamoto H; Ueba Y; Sudo Y; Sanada H; Yamamuro T; Takeda T
Hand; 1982 Oct; 14(3):237-47. PubMed ID: 6130030
[TBL] [Abstract][Full Text] [Related]
52. Investigating the effects of Pirfenidone on TGF-β1 stimulated non-SMAD signaling pathways in Dupuytren's disease -derived fibroblasts.
Zhou C; Zeldin Y; Baratz ME; Kathju S; Satish L
BMC Musculoskelet Disord; 2019 Mar; 20(1):135. PubMed ID: 30927912
[TBL] [Abstract][Full Text] [Related]
53. Dupuytren's palmar contracture in women.
Stahl S; Calif E
Isr Med Assoc J; 2008 Jun; 10(6):445-7. PubMed ID: 18669144
[TBL] [Abstract][Full Text] [Related]
54. Vitamin D deficiency may stimulate fibroblasts in Dupuytren's disease via mitochondrial increased reactive oxygen species through upregulating transforming growth factor-β1.
Seyhan H; Stromps JP; Demir E; Fuchs PC; Kopp J
Med Hypotheses; 2018 Jul; 116():40-41. PubMed ID: 29857907
[TBL] [Abstract][Full Text] [Related]
55. Connective Tissue Degeneration: Mechanisms of Palmar Fascia Degeneration (Dupuytren's Disease).
Karkampouna S; Kreulen M; Obdeijn MC; Kloen P; Dorjée AL; Rivellese F; Chojnowski A; Clark I; Kruithof-de Julio M
Curr Mol Biol Rep; 2016; 2(3):133-140. PubMed ID: 27617187
[TBL] [Abstract][Full Text] [Related]
56. Impact on costs of switching one-ray aponeurectomy to percutaneous needle aponeurotomy in Dupuytren's disease: A model analysis.
Maravic M; Beaudreuil J
Joint Bone Spine; 2015 Jul; 82(4):264-6. PubMed ID: 25857217
[TBL] [Abstract][Full Text] [Related]
57. The role of the fibroblast in Dupuytren's contracture.
Murrell GA
Hand Clin; 1991 Nov; 7(4):669-80; discussion 681. PubMed ID: 1769989
[TBL] [Abstract][Full Text] [Related]
58. Platelet-derived growth factor in Dupuytren's disease.
Badalamente MA; Hurst LC; Grandia SK; Sampson SP
J Hand Surg Am; 1992 Mar; 17(2):317-23. PubMed ID: 1564283
[TBL] [Abstract][Full Text] [Related]
59. Elevated transforming growth factor β and mitogen-activated protein kinase pathways mediate fibrotic traits of Dupuytren's disease fibroblasts.
Krause C; Kloen P; Ten Dijke P
Fibrogenesis Tissue Repair; 2011 Jun; 4(1):14. PubMed ID: 21711521
[TBL] [Abstract][Full Text] [Related]
60. Calcium-dependent signaling in Dupuytren's disease.
Hadeed JG; Bond JE; Selim MA; Bergeron A; Levin LS; Levinson H
Hand (N Y); 2011 Jun; 6(2):159-64. PubMed ID: 22654698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
